Should dopamine agonist treatment for prolactinomas be life-long?

Clin Endocrinol (Oxf). 1991 Mar;34(3):173-4. doi: 10.1111/j.1365-2265.1991.tb00288.x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dopamine Agents / administration & dosage
  • Dopamine Agents / therapeutic use*
  • Drug Administration Schedule
  • Humans
  • Pituitary Neoplasms / drug therapy*
  • Prolactinoma / drug therapy*

Substances

  • Dopamine Agents